The t(11;18) (q21;q21) translocation is a characteristic chromosomal aberration in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type. We previously identi®ed a YAC clone y789F3, which includes the breakpoint at 18q21 in a MALT lymphoma patient. BAC and PAC contigs were constructed on the YAC, and BAC 193f9 was found to encompass the breakpoint region. In the present study, we further narrowed down the breakpoint region at 18q21 in ®ve MALT lymphoma patients by means of FISH and Southern blot analyses using the plasmid contig constructed from BAC 193f9. The breakpoints at 18q21 in three of the ®ve MALT lymphoma patients were found to be clustered approximately within the 20 kb region. By using exon ampli®cation and cDNA library screening, we identi®ed a novel cDNA spanning the breakpoint region that exhibited aberrant mRNA signals in four of the ®ve MALT lymphoma patients. The nucleotide sequence predicted an 813 amino acid protein that shows signi®cant sequence similarity to the CD22b and laminin 5 a3b subunit. We refer to the gene encoding this transcript as MALT1 (Mucosa-Associated Lymphoid Tissue lymphoma translocation gene 1). The alteration of MALT1 by translocation strongly suggests that this gene plays an important role in the pathogenesis of MALT lymphoma.
Introduction
Extranodal lymphomas arising from the mucosaassociated lymphoid tissue (MALT) represent a subtype of B-cell non-Hodgkin's lymphoma (NHL) with a distinct clinicopathologic entity (Isaacson and Wright, 1983) . On the basis of their supposed cell of origin, these lymphomas have been recently de®ned as extranodal marginal zone B-cell lymphoma in the revised European-American classi®cation of lymphoid neoplasms (Harris et al., 1994) . Previous cytogenetic studies have identi®ed the t(11;18) (q21;q21) translocation as a recurring chromosomal abnormality in lowgrade MALT lymphoma (Levine et al., 1989; Grin et al., 1992; Horsman et al., 1992; Leroux et al., 1993; Ott et al., 1997) . Recently, the BCL10 gene was identi®ed from the breakpoint region at 1p22 of MALT lymphoma patients with t(1;14) (p22;q32) (Willis et al., 1999) . However, the frequency of the BCL10 gene alteration in MALT lymphoma patients remains to be studied.
We previously identi®ed a YAC clone, y789F3, which includes the breakpoint at 18q21, in a MALT lymphoma patient carrying the t(11;18) (q21;q21), and constructed a series of PAC and BAC contigs from the YAC clone (Akagi et al., 1999) . By employing FISH with these PAC and BAC clones, we then were able to identify a submicroscopic deletion associated with the t(11;18) translocation in the patient (Akagi et al., 1999) . We also found a submicroscopic deletion in another two MALT patients, and established that the common deleted region is located between the STS markers WI-2299 and D18S1103 (Tamura et al., manuscript submitted). The telomeric ends of the deletion were assigned to a speci®c region of approximately 100 kb: BAC 193f9 was found to include the telomeric ends of the deletion in two patients (Tamura et al. manuscript submitted) . In the present study, we attempted to identify the gene from 18q21 breakpoint region of the t(11;18)(q21;q21), which is most likely to be involved in the pathogenesis of MALT lymphoma. To this end, we ®rst narrowed down the breakpoint region at 18q21 with the aid of the plasmid contig constructed from BAC 193f9 and were able to identify a novel gene designated as MALT1 (Mucosa-Associated Lymphoid Tissue lymphoma translocation gene 1). Aberrant MALT1 mRNA signals were detected in four of ®ve MALT patients, which strongly suggests that MALT1 is a likely candidate gene involved in the pathogenesis of MALT lymphoma with t(11;18)(q21;q21).
Institute) is shown in Figure 1a . The FISH analysis with these BAC and PAC clones revealed that BAC 193f9 encompassed the breakpoints of cases 1 and 2 (Tamura et al. submitted). In order to narrow down the breakpoint region at 18q21, we constructed a plasmid contig from BAC 193f9. A lGET phage library was constructed from BAC 193f9 and 48 phage clones were randomly selected for further analysis. The phage clones were converted to plasmids, and then aligned to BAC 193f9 by means of dot blot hybridization analysis. Representative plasmid clones were shown in Figure 1b and these plasmid clones were used as probes for the FISH analysis. In case 1, the centromeric clones from the plasmid clone p7 were found to be deleted ( Figure 2a and Table 2 ), while the telomeric clones from the p5 showed two signals on normal chromosome 18 and on der(11) ( Figure 2b and Table 2 ), indicating that the breakpoint region is located between p7 and p5. In case 2, the centromeric clones from p13 were found to be deleted ( Figure 2c and Table 2 ), and the telomeric clones from p28 showed two signals on normal chromosome 18 and on der(11) ( Figure 2d and Table  2 ). Since p13 and p28 were found to overlap, the breakpoint region was assigned to within either p13 or p28. The distance between the two breakpoints in cases 1 and 2 was approximately 20 kb. In case 3, the PAC or BAC clones from 137d23 to 879n10 were deleted, suggesting that all plasmid clones on BAC 193f9 were deleted (Table 2) .
Southern blot analysis
To examine whether the plasmid clone p28 indeed encompasses the breakpoint of case 2, we performed 
Southern blot analysis with the patients' DNA samples. The p28 clone was digested by KpnI, EcoRI, and HindIII, and the 3.6 kb fragment (H/R 3.6 kb probe) was used as a probe ( Figure 3a ). In cases 2 and 4, the H/R 3.6 kb probe detected the rearranged bands of, respectively, 3.8 and 6.1 kb in EcoRI digestion (Figure 3b ), and these rearrangements were also detected with HindIII digestion (Figure 3c ). These results indicated that the breakpoints were located within the region detected by the probe. In cases 1 and 5, the probe detected only germline bands, which meant that the breakpoints were located outside of the region (Figure 3b ,c). Since the p28 region of case 3 was shown to be deleted by means of FISH analysis (Table  2) , Southern blot analysis was omitted. To con®rm whether the rearranged band was indeed involved in the t(11;18) translocation, the EcoRI 3.8 kb fragment detected in case 2 ( Figure 3b ) was cloned in the lgt10 vector. The nucleotide sequence of 316 bp from the centromeric end was found to be dierent from that of the chromosome 18 germline genomic sequence, and PCR-ampli®ed fragment of the centromeric 270 bp probe produced speci®c hybridization signals against the YAC clones of y906C5, y829A6, and y921F3 assigned to the 11q21 region (data bases of the MIT Center for Genome Research, data not shown).
Identi®cation of the gene at the 18q21 breakpoint region
In order to isolate the gene at 18q21 that encompasses the breakpoint in MALT lymphoma, we performed exon ampli®cation using pooled plasmid clones prepared from BAC 193f9, which resulted in the isolation of four fragments, ep4 ± 100, ep3 ± 300, ep2 ± 280 and ep3 ± 200 ( Figure 1b ). BLAST search identi®ed three ESTs that matched the nucleotide sequences of the ampli®ed fragments. The nucleotide sequences of ep2 ± 280 and ep3 ± 200 both matched that of EST AA826328 (GenBank Accession), the sequence of ep3 ± 300 matched that of EST AA214173, and the sequence of ep4 ± 100 that of EST AA191620. To assign these four fragments to the plasmid clones b c aligned with BAC193f9, each of the four fragments was hybridized to these plasmid clones. The results are shown in Figure 1b . ep2 ± 280 was assigned to plasmid clones p36, p13, and p1, indicating that this exon spans the breakpoints of cases 2 and 4. Since the breakpoint of case 1 was found to be located between p7 and p5 (Table 2 ), ep3 ± 300 must contain the breakpoint region of case 1. To determine the relationship between ep3 ± 300 and ep2 ± 280, we performed 5'RACE from ep2 ± 280, and found that the sequence of the 5'RACE product matched that of ep3 ± 300. This ®nding indicates that ep3 ± 300 and ep2 ± 280 represent parts of a single gene, and that the breakpoints of cases 1, 2 and 4 lie within the same gene. The gene encompassing the breakpoints of cases 1, 2 and 4 was named as MALT1 (Mucosa Associated Lymphoid Tissue lymphoma translocation gene 1) according to the suggestion by HUGO Nomenclature Committee, and the putative gene on chromosome 11 involved in the t(11;18) translocation was also suggested to designate as MALT2.
Next we attempted to isolate MALT1 cDNA by screening cDNA libraries made from the pre B cell line, KOCL-33 or the mantle cell lymphoma cell line, SP-49. As a result, ®ve overlapping cDNA clones were obtained from a total of 1.6610 6 recombinant clones. Sequence analysis predicted an 813 amino acid protein from the Kozak's consensus initiation codon at the nucleotide number 66 (Figure 4a ). The BLAST search with the predicted MALT1 protein revealed signi®cant homologies with CD22b and other related cell surface glycoproteins. Amino acids 116 ± 294 of MALT1 aligned with amino acids 233 ± 400 of CD22b demonstrated 25% identity and 39% similarity, while amino acids 121 ± 219 of MALT1 aligned with amino acids 590 ± 688 of CD22b showed 28% identity and 49% similarity (Figure 4b ). CD22b has been predicted to contain one NH 2 -terminal V-like domain and six C region-like domains (Wilson et al., 1991) . The homologous regions mentioned above corresponded to domains 3, 4 and 7 of CD22b.
Amino acids 246 ± 704 of MALT1 showed signi®cant homology with the predicted F22D3.6 gene product of Caenorhabditis elegans (Wilson et al., 1994) , and amino acids 308 ± 476 showed homology with the a3b subunit of laminin 5 (Ryan et al., 1994) . Amino acids 246 ± 704 of MALT1 aligned with amino acids 92 ± 605 of F22D3.6 gene product demonstrated 24% identity and 41% similarity (data not shown), while amino acids 308 ± 476 of MALT1 aligned with amino acids 543 ± 728 of a3b subunit of laminin 5 exhibited 24% identity and 41% similarity (Figure 4c ).
Northern blot analysis MALT1 expression was examined by Northern blot analysis in various human tissues (Figure 5a ). The most intense signals were demonstrated in the peripheral blood mononuclear cells (PBMNCs). The two major transcripts were found to be 4.5 and 3.1 kb in size, and the size of a minor transcript was 9.4 kb. Moderate to weak signals were also found in bone marrow, thymus, and lymph node. Very weak signals were found in the colon and lung, while no signals were detected in the liver under these test conditions. These results indicate that MALT1 is predominantly expressed in the hematolymphoid system. We therefore examined various hematopoietic cell lines and found signi®cant expression in all cell lines tested, including T, B and myeloid lineages (Figure 5b ). The size of the transcripts was identical to that found in PBMNCs. In order to study MALT1 expression in response to a growth signal, we investigated the mRNA expression of normal PBMNCs stimulated with phytohemaggulutin-P (PHA-P). The mRNA levels were found to gradually increase upon stimulation (Figure 5c ).
Finally, we analysed MALT1 expression in ®ve MALT patients' samples by means of Northern blot analysis. Interestingly, we found the aberrant MALT1 transcripts (indicated by arrows in Figure 5d ) in all cases except case 5. In cases 1 through 4, various kinds of signals above 4.5 kb were noted which were aberrant in comparison with the normal expression pattern shown in HL-60 cells. Case 1 showed very intense 9.4 kb signal, the size of which was identical to the normal 9.4 kb signal shown in HL-60 cells, but its intensity was signi®cantly dierent. Case 2 showed 8.7 and 6.4 kb aberrant transcripts which are dierent from the normal 9.4 kb signal. Cases 3 and 4 demonstrated 6.7 and 6.4 kb signals, respectively. No aberrant transcripts were apparent in case 5, probably because the transcript signals were weak. Thus, aberrant MALT1 transcripts were consistently detected in four MALT patients, which suggests that the MALT1 gene is a likely candidate gene involved in the pathogenesis of MALT lymphoma. When the PCR-ampli®ed probe made from 5' end to the breakpoint of case 1 was used, the aberrant transcripts were not detected but the two major transcripts of 4.5 and 3.1 kb were detected (data not shown), suggesting that the aberrant transcripts are most likely to be made as a result of t(11;18) translocation.
Discussion
The t(11;18) (q21;q21) translocation has been reported to be a recurrent chromosome aberration in small lymphocytic lymphoma or MALT lymphoma (Levine et al., 1989; Grin et al., 1992; Horsman et al., 1992; Leroux et al., 1993; Ott et al., 1997) . Recently, Stoel et al. (1999) reported that YAC y938E1 contained the breakpoint at 18q21 of three MALT lymphoma cases. We also identi®ed a YAC clone, y789F3, encompassing the breakpoint at 18q21 in a MALT lymphoma patient (Akagi et al., 1999) . However, the y789F3 is located centromerically at a distance of approximately 2 cM from y938E1. The reason for this dierence is currently unclear. Thus, identi®cation of gene(s) from both breakpoint regions is necessary in order to disclose the molecular pathogenesis of MALT lymphoma carrying t(11;18).
In the present study, we narrowed down the breakpoint at 18q21 and identi®ed the HindIII/EcoRI 3.6 kb (H/R 3.6 kb) DNA fragment that could detect the gene rearrangement in two of ®ve MALT patients. Furthermore, the breakpoint in case 1 was also found to be located near and¯anking the 3.6 kb fragment, approximately 20 kb upstream. These ®ndings suggest that some of the breakpoints at 18q21 are clustered in this region in MALT lymphoma. Thus, this 3.6 kb probe appears to be a potentially valuable tool for Southern blot analysis for the detection of t(11;18) (q21;q21) in MALT lymphomas.
By using exon ampli®cation and subsequent cDNA library screening, we identi®ed for the ®rst time a novel gene named MALT1 which encompassed the breakpoints in three of ®ve MALT patients with t(11;18) (q21;q21). The involvement of the MALT1 gene in the pathogenesis of MALT lymphoma has been strongly suggested by our ®nding of aberrant transcripts in four of ®ve MALT patients' samples. The open reading frame of the MALT1 cDNA sequence predicts an 813 amino acid protein that shows signi®cant homology to CD22b and F22D3.6 gene products. CD22 is a B lymphocyte speci®c glycoprotein and a member of the recently described sialoadhesion family of molecules (Law and Clark, 1994; Powell and Varki, 1995; Tedder et al., 1997) . CD22b is one of two isoforms of CD22, and has seven extracellular immunoglobulin-like domains and a cytoplasmic domain containing 141 amino acids (Wilson et al., 1991) . A homology search of MALT1 revealed similarities to the immunoglobulin-like domains 3, 4 and 7. When the C-terminal portion of MALT1 was searched with BLAST, it was found to be similar to the F22D3.6 gene product of Caenorhabditis elegans (Wilson et al., 1994) and the a3b subunit of laminin 5 (Ryan et al., 1994) . These ®ndings suggest that MALT1 is a newly identi®ed member of the immunoglobulin superfamily, and may function as an adhesion molecule. MALT1 was predominantly expressed in the hematolymphoid system, while in PHA-P stimulated PBMNCs, the expression of MALT1 was upregulated. These ®ndings also seem to indicate that MALT1 is associated with cell proliferation in hematopoietic-lymphoid cells.
The ®nding that the MALT1 gene spanned the breakpoint at 18q21 led to a prediction of altered transcripts. Although a detailed analysis of the aberrant transcripts needs to be conducted, they are likely to be the result of the fusion between MALT1 on chromosome 18 and a putative gene, MALT2, on chromosome 11. The breakpoints of cases 1, 2 and 4 are located in a predicted open reading frame, which suggests that the t(11;18) translocation will result in chimeric gene products. Although the breakpoint of case 3 was found to be located on a dierent BAC clone, 187o18, the Northern analysis demonstrated the presence of the altered transcript. This implies that MALT1 alteration was also involved in case 3, but that the expected chimeric product will be dierent from those produced from cases 1, 2 and 4. It is thus important to identify the putative MALT2 gene on chromosome 11.
In summary, the MALT1 gene found at the 18q21 breakpoint region is one of the most likely candidates involved in the pathogenesis of MALT lymphoma. Undoubtedly, the identi®cation of MALT2 gene on chromosome 11 and of the possible chimeric transcripts of MALT2 ± MALT1 resulting from the t(11;18) translocation would be a promising next step in identi®cation of the molecular mechanism of MALT lymphoma development. Such studies should provide not only new insights into lymphomagenesis but also a better understanding of hematopoietic-lymphoid cell dierentiation and proliferation.
Materials and methods

Patient samples
Tumors from ®ve patients with MALT lymphoma carrying t(11;18) were studied. The pathologic diagnosis was established according to the REAL classi®cation (Harris et al., 1994) . The clinical, immunophenotypic, and cytogenetic ®ndings are summarized in Table 1 .
Fluorescence in situ hybridization (FISH)
Three patients' lung tumor cells (cases 1, 2 and 3) could be used for FISH analysis. Metaphase spreads were prepared from short-time cultures of tumor cells obtained from the lung, and ®xed in methanol:acetic acid 3 : 1 (v/v). The hybridization mixture contained approximately 150 ng of labeled PAC, BAC, and plasmid DNA, 10 ± 15 mg of Cot-1 DNA, and 500 ng of chromosome speci®c library DNA. Hybridization was performed with a method described previously (Taniwaki et al., 1995) . The plasmid libraries from sorted human chromosomes 11 and 18 were a generous gift from Dr JW Gray (University of California at San Francisco, CA, USA) and Thomas Cremer (Munich University), and were used as whole chromosome painting (WCP) probes.
DNA extraction and Southern blot analysis
DNA was puri®ed by digestion with proteinase K,`saltingout' puri®cation, and precipitation by ethanol as described elsewhere (Miller et al., 1988) . Southern blot analysis was conducted as described previously (Seto et al., 1992) . Sonicated human placental DNA was used at a ®nal concentration of 100 mg/ml to reduce reiterated signals.
Construction of a genomic library from a MALT patient
In order to isolate the rearranged band of 3.8 kb in case 2, a genomic library was constructed in phage vector lgt10 (Stratagene, La Jolla, CA, USA). High molecular weight DNA extracted from case 2 was completely digested with EcoRI, and size fractionated on a low melting point agarose gel. The DNA ranging from 3 to 6 kb was then puri®ed, ligated into the lgt10 vector and in vitro packaged. The library was screened with the H/R 3.6 kb probe of p28 which detected the gene rearrangement.
Preparation of YAC DNA
YAC clones were obtained from the Centre d'Etude du Polymorphisme Humain (CEPH) or from Research Genetics Inc. (Huntsville, AL, USA) based on the data bases of the MIT Center for Genome Research and the NCBI (National Center for Biotechnology Information). YAC DNA was prepared according to a previously described method (Silverman, 1995) .
Construction of a plasmid contig on BAC 193f9
BAC DNA was prepared according to the manufacturer's protocol (Genome Systems Inc., St Louis, MO, USA). A library from BAC 193f9 was constructed in the lGET phage vector (Nehls et al., 1994) , which was a generous gift from Dr Thomas Boehm at the Max-Planck-Institute. BAC DNA was partially digested with Sau3A, and size fractionated on a low melting point agarose gel. The DNA ranging from 15 to 23 kb was puri®ed, and, after ligation into the lGET vector and in vitro packaging, the lGET recombinants were plated at low density on the plate. Forty-eight individual plaques were randomly isolated, and were converted to plasmids by infecting them with E. coli BNN132 (Nehls et al., 1994; Elledge et al., 1991) . Plasmids were puri®ed with the alkaline lysis/PEG procedure (Sambrook et al., 1989) . To generate a plasmid contig on the BAC 193f9, the entire plasmid inserts were used as probes to group plasmid clones dot-blotted on a hybridization membrane as described previously (Akagi et al., 1999) . In addition, speci®c end probes of BAC 193f9 were used to determine the orientation of the plasmid contig.
Exon ampli®cation
The plasmid clones converted from lGET recombinants were used for exon ampli®cation. Eight to ten plasmid clones were pooled and used for transfection. Transfection of the plasmid clones to COS7 cells, and the subsequent RT±PCR were performed according to a method described previously (Nehls et al., 1994) . The ampli®ed exons were directly sequenced and assigned to speci®c plasmid clones by means of dot-blot hybridization.
DNA sequencing and homology search
Nucleotide sequences were determined with the dideoxy chain termination method using an ABI PRISM TM Dye Terminator Cycle Sequencing Ready Reaction kit (Perkin Elmer, Foster City, CA, USA). Homologies to known multiple human expressed sequence tags (ESTs) were identi®ed by searching the Genbank EST database (dbEST) with exons via the NCBI server using the BLAST algorithm (Altschul et al., 1990) .
5'RACE ± PCR
5'RACE±PCR was performed by using the 5'RACE System for Rapid Ampli®cation of cDNA Ends, Version 2.0, according to the manufacturer's protocols (GIBCO BRL, Gaithersburg, MD, USA). Brie¯y, 5 mg of the tested RNAs extracted from the colon were reverse transcribed with a primer ep2-280 420AS (5'-AACTCATCCACAGCATTACG-3') for the antisense orientation. After C-tailing with terminal deoxynucleotidyl transferase, nested ampli®cation was performed by using the primer ep2-280 500 AS (5'-TAGTCAATTCGTACACATCC-3') and the 5'RACE abridged anchor primer in the kit. One-hundredth of the PCR product was then reampli®ed with the primer ep2-280 540AS (5'-GGTGCTCCCGGTAATTCATT-3'), and an abridged universal ampli®cation primer. The resultant products were puri®ed with a low melting point gel and subcloned into the plasmids (PBluescript TM SK-, Stratagene, La Jolla, CA, USA) by means of the T/A subcloning system (Sarkar et al., 1993) .
Screening of cDNA library
A total of 8610 5 recombinant clones of the cDNA library prepared in the lgt10 vector with a B-cell tumor cell line, KOCL33, and a total of 8610 5 recombinant clones of the cDNA library of SP-49 (Yamamoto et al., 1993) were screened with the cDNAs obtained from exon ampli®cation and 5'RACE products. cDNA walking was also conducted.
Northern blot analysis
Total cellular RNAs were extracted from exponentially growing cells or from either frozen or fresh patient samples by means of the guanidium-isothiocyanate cesium-chloride method. The hybridization for Northern blot analysis was performed as described previously (Seto et al., 1992) .
Cell lines
Nine hemotopoietic cell lines (two from T-cell tumors, six from B-cell tumors, and one from a myeloid tumor) were examined for Northern blot analysis. Some of these cell lines were kindly provided by Dr Nakazawa at Yamanashi Medical College, Dr Kubonishi at Kochi Medical College, and Dr. Minden at the Ontario Cancer Institute.
Phytohemagglutinin stimulation of peripheral blood mononuclear cells
Peripheral blood mononuclear cells (PBMNCs) from a normal individual were separated by means of FicollHypaque gradient centrifugation and cultured in RPMI 1640 with 5% fetal calf serum (FCS) in the presence of 0.1% phytohemaggulutin-P (PHP-P; Difco Laboratories, Detroit, MI, USA) in a 5% CO 2 incubator at 378C for 72 h. Total RNAs were isolated at 0, 24 and 72 after the stimulation.
Note added in proof
After submission of our manuscript, Dierlamm et al. reported a chimeric transcript resulting from t(11;18) translocation (Blood 93: 3601 ± 3609, 1999) . They found that human c-IAP2 (HIAP1) gene at 11q21 is fused to a gene, named MLT, at 18q21. Of note, the C-terminal portion of MLT to the breakpoint showed the identical amino acid sequence to amino acids 127 ± 813 of MALT1 in our study except for 11 amino acids which are located between the amino acids 308 and 309 of MALT1. The dierence would be generated from alternative splicing. Our preliminary analysis has also established that human c-IAP2 (HIAP1) gene is certainly fused to the MALT1 gene in our series with t(11;18) (q21;q21).
